Ambrisentan and shock haemorrhagic Patient Reports February 11, 2012
Ambrisentan Side Effects Report #5597745-7
Ambrisentan side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 16, 2008. Female patient, weighting 246.7 lb, was diagnosed with pulmonary hypertension
and was treated with Ambrisentan. After drug was administered, patient experienced the following side effects: shock haemorrhagic. Ambrisentan dosage: unknown. During the same period patient was treated with OXYGEN, CARVEDILOL, LISINOPRIL, DIGOXIN, FUROSEMIDE, METOLAZONE, ALLOPURINOL, GLUCOVANCE. Patient was hospitalized. Patient recovered.Ambrisentan Side Effects Report #5602590-X
Ambrisentan side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 16, 2008. Female patient, weighting 246.7 lb, was diagnosed with pulmonary hypertension
and was treated with Ambrisentan. After drug was administered, patient experienced the following side effects: shock haemorrhagic. Ambrisentan dosage: unknown. During the same period patient was treated with OXYGEN, CARVEDILOL, LISINOPRIL, DIGOXIN, FUROSEMIDE, METOLAZONE, ALLOPURINOL, GLUCOVANCE. Patient was hospitalized. Patient recovered.Ambrisentan Side Effects Report #5772826-3
Ambrisentan side effect was reported by a Consumer or non-health professional from UNITED STATES on June 05, 2008. Female patient, weighting 246.7 lb, was diagnosed with pulmonary arterial hypertension and was treated with Ambrisentan. After drug was administered, patient experienced the following side effects: shock haemorrhagic, vaginal haemorrhage. Ambrisentan dosage: unknown. During the same period patient was treated with OXYGEN, CARVEDILOL, LISINOPRIL, DIGOXIN, FUROSEMIDE, METOLAZONE, ALLOPURINOL. Patient was hospitalized. Patient recovered.
Ambrisentan Side Effects Report #5808013-X
Ambrisentan side effect was reported by a Consumer or non-health professional from UNITED STATES on July 03, 2008. Female patient, weighting 246.7 lb, was diagnosed with pulmonary arterial hypertension and was treated with Ambrisentan. After drug was administered, patient experienced the following side effects: shock haemorrhagic, vaginal haemorrhage. Ambrisentan dosage: unknown. During the same period patient was treated with OXYGEN, CARVEDILOL, LISINOPRIL, DIGOXIN, FUROSEMIDE, METOLAZONE, ALLOPURINOL. Patient was hospitalized. Patient recovered.
Ambrisentan and shock haemorrhagic 